Literature DB >> 19103725

Randomized, double-blind, placebo-controlled trial of epoetin alfa in men with castration-resistant prostate cancer and anemia.

Eric Winquist, Jim A Julian, Malcolm J Moore, Abdenour Nabid, Jinka Sathya, Lori Wood, Peter Venner, Mark Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19103725     DOI： 10.1200/JCO.2008.20.4966

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Erythropoietin or darbepoetin for patients with cancer.

Authors:  Thomy Tonia; Annette Mettler; Nadège Robert; Guido Schwarzer; Jerome Seidenfeld; Olaf Weingart; Chris Hyde; Andreas Engert; Julia Bohlius
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 2.  [Systemic treatment of metastatic prostate cancer].

Authors:  B Wörmann; J M Wolff
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

Review 3.  Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis.

Authors:  Anne Adams; Benjamin Scheckel; Anissa Habsaoui; Madhuri Haque; Kathrin Kuhr; Ina Monsef; Julia Bohlius; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2022-06-20

Review 4.  Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.

Authors:  J Bohlius; T Tonia; E Nüesch; P Jüni; M F Fey; M Egger; J Bernhard
Journal:  Br J Cancer       Date:  2014-04-17       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.